tradingkey.logo

NeuroOne Medical Technologies Corp

NMTC

0.930USD

+0.030+3.34%
終値 09/19, 16:00ET15分遅れの株価
46.34M時価総額
損失額直近12ヶ月PER

NeuroOne Medical Technologies Corp

0.930

+0.030+3.34%
詳細情報 NeuroOne Medical Technologies Corp 企業名
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
企業情報
企業コードNMTC
会社名NeuroOne Medical Technologies Corp
上場日Nov 09, 2012
最高経営責任者「CEO」Mr. David A. (Dave) Rosa
従業員数17
証券種類Ordinary Share
決算期末Nov 09
本社所在地7599 Anagram Dr
都市EDEN PRAIRIE
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号55344-7399
電話番号19524261383
ウェブサイトhttps://nmtc1.com/
企業コードNMTC
上場日Nov 09, 2012
最高経営責任者「CEO」Mr. David A. (Dave) Rosa
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
618.21K
-0.40%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
231.24K
-11.48%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
136.80K
+25.48%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
114.41K
+32.06%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
102.66K
-0.87%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+43.25%
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
618.21K
-0.40%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
231.24K
-11.48%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
136.80K
+25.48%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
114.41K
+32.06%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
102.66K
-0.87%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+43.25%
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sun, Aug 17
更新時刻: Sun, Aug 17
株主統計
種類
株主統計
株主統計
比率
Merchant Adventure Fund LP
8.40%
Bleichroeder LP
8.00%
Sio Capital Management, LLC
7.05%
Manchester Management Company, L.L.C.
4.73%
Bard Associates Inc.
3.71%
他の
68.12%
株主統計
株主統計
比率
Merchant Adventure Fund LP
8.40%
Bleichroeder LP
8.00%
Sio Capital Management, LLC
7.05%
Manchester Management Company, L.L.C.
4.73%
Bard Associates Inc.
3.71%
他の
68.12%
種類
株主統計
比率
Investment Advisor
17.48%
Hedge Fund
12.99%
Corporation
8.40%
Individual Investor
4.18%
Investment Advisor/Hedge Fund
2.87%
Venture Capital
0.15%
Research Firm
0.14%
他の
53.79%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
52
13.28M
26.66%
+2.81M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
2023Q3
54
7.90M
33.50%
+2.01M
2023Q2
48
4.40M
25.73%
-1.65M
2023Q1
47
4.27M
25.69%
-1.26M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Merchant Adventure Fund LP
4.20M
8.43%
+2.95M
+236.00%
Dec 31, 2024
Manchester Management Company, L.L.C.
2.36M
4.75%
+864.05K
+57.60%
Jan 03, 2025
The Vanguard Group, Inc.
1.11M
2.23%
+191.16K
+20.79%
Mar 31, 2025
AWM Investment Company, Inc.
1.17M
2.34%
--
--
Mar 31, 2025
Rosa (David A)
618.21K
1.24%
-2.46K
-0.40%
Jun 30, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI